Resource Center

A New End-To-End CDMO Takes Shape: What Does Adare’s Acquisition of Frontida Mean for the Industry? - Adare Pharma Solutions

Written by Adare Pharma Solutions | Mar 15, 2026 4:00:00 AM

With the acquisition of Frontida, Adare Pharma Solutions has taken a major step toward becoming a fully integrated, end-to-end CDMO. In this interview, Tom Sellig explains how the expanded global footprint, enhanced capabilities, and increased agility are helping Adare better support customers from early development through commercialization.